Navigation Links
Coated Stents Better Than Bare Metal Ones in Short Run
Date:12/18/2008

But slightly higher mortality rates showed up after 3 years, study finds

THURSDAY, Dec. 18 (HealthDay News) -- Angioplasty patients who receive stents coated with medication to prevent narrowing of the artery do better one year after the surgery than those who receive bare metal stents, a new study shows.

However, within three years of the procedure, patients with these drug-eluting stents (DES) face a greater risk of more surgery to increase blood flow or even death, according to the study of 6,440 patients, expected to be published in the Jan. 20 issue of CMAJ.

"Despite recent concerns surrounding drug-eluting stent safety, the long-term survival [to three years] of patients receiving drug-eluting stents remains globally favorable and certainly not measurably worse than that of patients treated with bare metal stents," study co-authors Drs. William Ghali and Andrew Philpott of the University of Calgary, said in a journal news release. "However, we did observe a concerning risk trend toward accelerating adverse events in the DES group late in the follow-up period -- a finding that underlines the need for ongoing surveillance of longer-term outcomes."

The study found that the death rate for people with drug-eluting stents was significantly lower than for those with bare metal stents in the first 30 days after the operation. It also noted that DES patients tended to be women and also had higher rates of kidney disease, diabetes, high cholesterol and hypertension.

In a related commentary to be published on the journal's Web site later this week, Columbia University Medical Center Drs. Philippe Généreux and Roxana Mehran wrote that, despite increasing positive study results about drug-eluting stents, their long-term safety is still a concern, citing particular concerns about the development of stent thrombosis.

More information

The U.S. Food and Drug Administration has more about drug-eluting stents.



-- Kevin McKeever



SOURCE: CMAJ, news release, Dec. 18, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Drug-Coated Stents Go Head to Head
2. Study Finds Benefits With Drug-Coated Stents
3. New Canadian study finds drug coated heart stents to be safe:
4. Starpharma and Durex Sign Co-Development Agreement for VivaGel(R)-Coated Condoms
5. Drug-Coated Stents No Riskier in Long Run Than Bare Metal Ones
6. Study Finds Both Coated Stents Perform the Same
7. Drug-Coated Stents Better Than Bare-Metal Ones in Complex Cases
8. Drug-Coated Balloons Keep Leg Arteries Open: Study
9. Drug-coated balloon overcomes in-stent restenosis
10. New Drug-Coated Stent Does Well in Early Trial
11. Perrigo Receives FDA Approval to Market Orange, Coated Nicotine Gum
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Coated Stents Better Than Bare Metal Ones in Short Run
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 26, 2016 One of Australia,s ... the formation of a new biotechnology company, Noxopharm Limited [ABN 50 ... an IPO and to list on the ASX. Noxopharm ... ready to enter a Phase 1 clinical study later this year. ... address one of the biggest problems facing cancer patients - the ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: